Loss of stemness in p53-proficient GBM-SCs was accompanied by the loss of FoxO proteins, which so far have been reported to negatively regulate stemness in solid-tumor CSCs [43–47] or related processes [52]. The gene discussed is TP53; the disease is glioblastoma.